Skip to main content

Table 2 Plausibility and relevance of published sampling schemes using data from three empirical surveys

From: Improving valuation sampling of EQ-5D health states

  Valuation study
  UK / Spain / US Denmark Germany Japan / Netherlands
States valued# 43 47 36 18
States valued but not present in observational data set /implausible
HSE96 12 (28%) 10 (23%) 9 (21%) 5 (12%)
CODE-2 9 (21%) 7 (16%) 5 (12%) 4 (9%)
HoDAR 3 (7%) 2 (5%) 1 (2%) 2 (5%)
Coverage of total responses in observational data set /relevance
HSE96 82% 88% 82% 74%
CODE-2 63% 78% 68% 49%
HoDAR 58% 75% 57% 44%
  1. # including ‘no problems’ state (11111).
  2. HSE96 Health Survey for England 1996 [11].
  3. CODE-2 Cost of Diabetes in Europe: Type-2 [12].
  4. HoDAR Health Outcomes Data Repository [10].